[Other] A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma

T.E. Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-03 15:04
Reward20points

journalㄩBlood

AuthorsㄩHans C. Lee; Wouter J. Plattel; Simon J. Harrison; Douglas W. Sborov; Suzanne Lentzsch; Andrew Spencer; Ruben Niesvizky; Suzanne Trudel; Peter Mollee; Ravi Vij; Monique C. Minnema; Leo Rasche; Vijay V. Upreti; Di Zhou; Qing Xia; Mihaela Talpes; Tobias Eggert; Prashant Kapoor; Sikander Ailawadhi

Published dateㄩ2026-7-9

DOIㄩ10.1182/blood.2025032044

PDF linkㄩhttps://ashpublications.org/bloo ... 025-032044-main.pdf

Article linkㄩhttps://doi.org/10.1182/blood.2025032044

Article SourceㄩAmerican Society of Hematology


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    80


Return to the list